Metastatic lung adenocarcinoma presenting with central diabetes insipidus
This lung cancer diagnosis at a glance
- Stage at diagnosis
- Stage IV
- Subtype
- Non-Small Cell Lung Cancer
- Biomarkers
- Weak TTF-1-positive; weak Napsin A-positive; weak p63-positive; CK5/6-negative; molecular testing not performed because of financial constraints
- Sex
- Male
- Spread to
- brain lesions, cervical spine bone lesions
- Treatment
- supportive care and chemotherapy
- Outcome
- In Memory
Treatment course, step by step
- Central diabetes insipidus treated with intranasal desmopressin, increased from 1 puff daily to 2 puffs daily with symptomatic improvement
- metastatic lung adenocarcinoma diagnosed after brain MRI, cervical spine bone lesions, chest CT, and transbronchial biopsy
- systemic platinum-based chemotherapy for 2 cycles on day 1 and day 8 after admission
- patient deteriorated and died shortly after the second chemotherapy cycle.
What happened, in summary
This 50-year-old Iranian man came to the hospital with 20 days of polyuria and polydipsia. Initial tests showed low urine specific gravity and high serum sodium, and he was referred with suspected diabetes insipidus. Intranasal desmopressin was started at 1 puff daily, then increased to 2 puffs daily after 3 days, which improved his symptoms. The pattern suggested a central cause, meaning the problem was not simply excess fluid intake or kidney-related water loss. Brain MRI showed a normal pituitary gland and surrounding sellar structures, but hyperintense lesions were present in the right rectus gyrus and left occipital lobe. Imaging also showed multiple metastatic bone lesions in the cervical spine. A more detailed history then revealed about 10 kg of unintentional weight loss over 3 months. Chest CT showed consolidation with air bronchograms, patchy ground-glass opacities, and multiple nodules in the right upper lobe, along with bilateral mediastinal and hilar lymphadenopathy and bilateral pleural effusion. Transbronchial lung biopsy showed atypical epithelial cells with large, pleomorphic, hyperchromatic nuclei, consistent with lung adenocarcinoma. Immunohistochemistry was weakly positive for TTF-1, Napsin A, and p63, while CK5/6 was negative. Molecular testing for driver mutations could not be performed because of financial constraints. He was admitted to hemato-oncology and began systemic platinum-based chemotherapy, given on day 1 and day 8 after admission, while desmopressin continued to address the diabetes insipidus symptoms. Despite treatment, his condition deteriorated, and he died shortly after the second chemotherapy cycle. The case highlights lung adenocarcinoma presenting through central diabetes insipidus without visible pituitary metastasis.
Where this story comes from
This is a lay summary of an account first published by PMC / PubMed Central. Read the original in full
How we source and attribute stories Accuracy and limitations
Collections this story belongs to
- Stage 4 Lung Cancer 384 stories
- Chemotherapy for Stage 4 Lung Cancer 217 stories
- Chemotherapy for Lung Cancer 386 stories
These are lay summaries of published cancer stories, for information only. No two cancers behave the same way, and nothing here predicts your own diagnosis or replaces advice from your oncology team. Read the full disclaimer